HIV-associated parkinsonism with levodopa-induced dyskinesia and response to highly-active antiretroviral therapy

Movement Disorders

Volumn 24, Issue 16, 2009, Pages 2441-2442

  Kobylecki, Christopher ^a,b   Silverdale, Monty A ^a   Varma, Anoop ^a   Dick, Jeremy P R ^a   Kellett, Mark W ^a  

^a HOPE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; APOMORPHINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LAMIVUDINE PLUS ZIDOVUDINE; LEVODOPA; LOPINAVIR PLUS RITONAVIR; PRAMIPEXOLE;

ADULT; BRADYKINESIA; CASE REPORT; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID ANALYSIS; CONTINUOUS INFUSION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG WITHDRAWAL; DYSKINESIA; GAMMOPATHY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN BLOOD LEVEL; LETTER; LYMPHOCYTE COUNT; MALE; MUSCLE RIGIDITY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PRIORITY JOURNAL; SEBORRHEIC DERMATITIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT RESPONSE; TREMOR; VIRUS LOAD;

ADULT; AKATHISIA, DRUG-INDUCED; ANTIPARKINSON AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; LEVODOPA; MAGNETIC RESONANCE IMAGING; MALE; PARKINSONIAN DISORDERS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 73949116339     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22860     Document Type: Letter

References (9)

1. Mirsattari SM, Power C, Nath A. Parkinsonism with HIV infection. Mov Disord 1998;13:684-689.
2. Tse W, Cersosimo MG, Gracies JM, Morgello S, Olanow CW, Koller W. Movement disorders and AIDS: a review. Parkinsonism Relat Disord 2004;10:323-334.
3. Cardoso F. HIV-related movement disorders: epidemiology, pathogenesis, and management. CNS Drugs 2002;16:663-668.
4. Hersh BP, Rajendran PR, Battinelli D. Parkinsonism as the presenting manifestation of HIV infection: improvement on HAART. Neurology 2001;56:278-279.
5. Reyes MG, Faraldi F, Senseng CS, Flowers C, Fariello R. Nigral degeneration in acquired immune deficiency syndrome (AIDS). Acta Neuropathol (Berl) 1991;82:39-44.
6. Bennett BA, Rusyniak DE, Hollingsworth CK. HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures. Brain Res 1995;705:168-176.
7. Rottenberg DA, Moeller JR, Strother SC, et al. The metabolic pathology of the AIDS dementia complex. Ann Neurol 1987;22:700-706.
8. Sporer B, Linke R, Seelos K, Paul R, Klopstock T, Pfister HW. HIV-induced chorea: evidence for basal ganglia dysregulation by SPECT. J Neurol 2005;252:356-358.
9. Wang GJ, Chang L, Volkow ND, et al. Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain 2004;127:2452-2458.